MEDIA RELEASE PR36309
Neopharma Receives Approval From UAE Ministry of Health to Manufacture H1N1 Medicine
DUBAI, Sept. 28 /PRNewswire-AsiaNet/ --
Neopharma, the Abu Dhabi-based pharmaceuticals manufacturer, today announced it has received
clearance from the UAE Ministry of Health for the production of an antiviral medication Oseltamivir BR Flu.
The approval comes at a time when the entire region is stepping up efforts to tackle the H1N1 pandemic.
The drug is a potential choice to prevent and treat H1N1 flu in the region.
His Excellency Abdulla Humaid Al Mazroei, Vice-Chairman, Neopharma, and Dr. B.R. Shetty, Managing
Director and CEO, thanked the UAE Ministry of Health on behalf of the Board of Directors of the company.
Dr. Shetty said: "The endorsement for the antiviral drug to be manufactured by Neopharma reflects the
strong support of the Ministry of Health for the vision of the UAE leadership to create a self-sustaining
community. As a leading manufacturer of life-saving drugs, we believe it is our responsibility to play a vital role
in helping the community at this critical juncture.
"We are confident the approval for Oseltamivir will significantly facilitate medical professionals and the wider
community to effectively combat the lethal H1N1 virus in the region."
Neopharma's Oseltamivir BR Flu is the outcome of a joint venture with leading pharmaceuticals major
Hetero Drugs Ltd and is the first in a series of major life-saving drugs the company plans to produce over the
next few years.
Currently, Neopharma has independent production blocks for the manufacture of general and betalactam
products. The company's plant in Abu Dhabi is designed for the large-scale production of tablets, capsules
and liquid orals.
About Neopharma:
Neopharma is a premier pharmaceuticals manufacturing company based in Abu Dhabi. Set up in October
2003, Neopharma manufactures a wide range of products including antibiotics, analgesics, respiratory
medicines, antihistamines, as well as medications for cardiovascular conditions and diabetes. A robust R&D
centre, hi-tech manufacturing and quality embedded operations make the company a manufacturer of world-
class pharmaceutical products.
Neopharma has received the prestigious Mohammed bin Rashid Al Maktoum Award in the manufacturing
category and is also the recipient of the current European Good Manufacturing Practice Guidelines
Certification from Belgium. The company has received the ISO 9001, ISO 14,001 and OHSAS 18,001
certifications for integrated management system encompassing quality, environment and safety standards.
For further information, please call:
Zeba Ahmad
JiWin
Tel: +9714-361-3590
e-mail: Zeba.Ahmad@jiwin.ae
SOURCE: Neopharma
NEWS 
